Intravesical Therapy for Bladder Cancer

Date

November 5, 2012

Credits

1 CH | 30 Rx | Expired November 2, 2014

$30

Standard Price

This presentation will describe bladder cancer; surgery; and follow-up treatments. It will focus on BCG; but will include other intravesical therapeutic agents; their handling; use; results and patient education.

Learning Objectives:

Describe when BCG is indicated for use in Bladder Cancer.
List the side effects associated with BCG instillations.
Discuss the appropriate aftercare instructions to be reviewed with patients receiving BCG.
Describe other intravesical treatments used; when indicated and possible side effects.

Speaker

Leanne S. Schimke, MSN, CRNP, FNP-C, CUNP

Nurse Practitioner

Related Products

Advanced Prostate Cancer Update: Breaking Barriers

Advanced prostate cancer treatments continue to evolve with new treatments in the M0CRPC, such as daralutamide and apalutamide, precision treatments based on genetic testing including PARP inhibitors and PD1 immunotherapy…

Lunch Symposium: Metastatic Hormone-Sensitive Prostate Cancer: New Treatment Options

This activity is designed to help urology advanced practice providers and nurses understand best practice approaches for identifying metastatic hormone-sensitive prostate cancer to ensure optimal patient outcomes…

Lunch Symposium - Non-Metastitic Prostate Cancer: The Right Treatment for the Right Patient at the Right Time

This session will help urology nurses/APNs understand best practice approaches for identifying non-metastatic prostate cancer patients to ensure optimal patient outcomes…

History of Prostate Cancer Over the Last 50 Years

CONTACT HOURS AVAILABLE UNTIL 10/31/2021…